Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Books about substance abuse treatment for professionals written by our faculty members.
Division of Chemical Dependence - Johns Hopkins Bayview Medical Center
Medical students, residency training
Neurobiology of Substance Use Disorders
Joint NIDA IRP - JH Course
Department of Neurosciences
Monday and Wednesday | 3-4 PM | Wood basic Science Building
Antonello Bonci, M.D. NIDA-IRP, Hopkins Neuroscience
Jean Lud Cadet, M.D. NIDA-IRP
Eric Strain, M.D., Hopkins Medicine
Description of the course. Recent progress in basic and clinical neurobiology has helped to identify specific cellular and molecular mechanisms that are involved in the development and maintenance of drug-taking behaviors. Similarly, clinical studies have identified behavior patterns and brain structures that are relevant to drug addiction, Thus, the purpose of this course is to provide an overview of the neural circuitries and of the molecular and cellular mechanisms involved in the addictive process. The lecturers will also provide an overview of the clinical presentations and course of substance use disorders. The course will consist of 14 lectures given over a period of 8 weeks, with 2 hourly lectures per week. Topics will include the amphetamines, cocaine, heroin, marijuana, and designer drugs.
Johns Hopkins/ NIDA Intramural Research Program
Joint Fellowship in Aging and Addicition
VISION | To develop a collaborative program that will lead the nation in conducting research and training that pertains to aging and addiction.
OVERVIEW | This will be a joint program that is co-directed by Johns Hopkins, the National Institute on Drug Abuse Intramural Research Program (NIDA IRP), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Institute on Aging. A central feature to the program is a training program for doctoral level young investigators. In addition, there will be associated seminars and educational initiatives consistent with the overall theme of aging and addiction. The training program will last a total of five years for each enrollee, and will provide a clinical and research training experience for physicians and psychologists who wish to develop expertise in the area of aging and addictions. The five-year period will begin with a two-year fellowship, followed by a three-year JH faculty and/or IRP staff appointment. Full salary support for the two-year fellowship will be guaranteed contingent on productivity and participation, and salary support consistent with rank/appointment level will be guaranteed (contingent on productivity and participation) by the program for years 3-5. Effort during the fellowship years will be broadly split between clinical work in the area of addictions and aging, and research experience (either clinical or preclinical) as it relates to this area. Years 3-5 will be tailored based upon the interests, productivity, and opportunities identified in years 1-2.
TARGET ENROLLEES | This program will target physicians and psychologists with an interest in aging and addictions. Enrollees will not be limited to graduates of the Hopkins training programs, and the program will not be restricted to any particular medical specialty for physician enrollees.
ASSOCIATED FEATURES OF THE PROGRAM | In addition to the training program, there are two associated features to this joint aging/addictions program. The first is a monthly seminar luncheon seminar series that will focus on issues of aging and addictions. Fellows in the program will help to organize this series with the assistance of their mentors and the program co-directors; seminars will be open to the general scientific community. The second feature is an annual speaker, who will be a nationally recognized person that ideally has expertise in the areas of aging and addictions. This speaker will be invited to the JHBMC campus for the day to give a major presentation.
Drug Dependence Epidemiology Training (DDET) Program
The Drug Dependence Epidemiology Training (DDET) Program is a T32 research training program in the epidemiology of drug dependence. It is housed in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. The DDET Program currently funds 14 trainees: 7 predoctoral students and 7 postdoctoral fellows. The DDET Program is supported primarily by T32 research training grant awards from the National Institute on Drug Abuse of the NIH Fogarty International Center. Dr. C. Debra Furr-Holden is the training program director.
The Drug Dependence Epidemiology Training Program is designed to develop expert scientists in the field of the epidemiology and consequences of drug dependence. A primary goal of research emphasized within the DDET Program is to explicate biological and environmental factors associated with changes in drug-taking behavior, variations in problem severity of drug use, and risk and protective factors associated with the consequences of drug-taking behavior, including infectious disease, cancer, or dementia, in addition to complications associated with prenatal drug exposure.
Predoctoral and postdoctoral trainees are encouraged and expected to develop research projects and submit manuscripts for publication in scientific journals. They are also expected to present their work at scientific conferences. Collaboration is highly encouraged, within and outside of the DDET group.
For more information: http://web.jhu.edu/ddeRenee M. Johnson, PhD, MPHAssistant Professor, Johns Hopkins Bloomberg School of Public HealthDept. of Mental Health, Deputy Director, Drug Dependence Epidemiology Training Program (DDET)624 North Broadway, 8th Floor, Room 801Baltimore MD 21205-1999TEL (410) 955-7073FAX (410) 955-9088EMAIL email@example.com
Sexually Transmitted Infection (STI) Training Grant
The Sexually Transmitted Infection (STI) Training Grant is an NIAID T32 pre-doctoral research training program for 5 pre-doctoral students . While the administrative home of the training grant is in the Department of Epidemiology, the training grant recruits pre-doctoral trainees from all Departments within the Johns Hopkins Bloomberg School of Public Health. It is co-directed by Drs. Jacky Jennings (SOM) and Susan Sherman (SPH). The STI TG’s primary goal is to create a rich and interactive research training environment. Mentoring is provided by the Co-Directors and academic advisors across the Johns Hopkins University Institution. Grantees are exposed to innovative, productive, and collaborative STI research conducted by observational, basic, and clinical research scientists.
The training grant aims to advance knowledge of the causes of STIs like sexually transmitted HIV, including inherent and modifiable factors in human populations. Further, it aims to advance knowledge about the diagnosis, care, and treatment of STIs including HIV in individuals and in human populations. Lastly, the training grant seeks to extend knowledge of how to prevent and reduce the burden of STIs by providing a better understanding of sexual risk behaviors and transmission dynamics; identifying social determinants of sexually transmitted diseases; and identifying and addressing barriers to care. Trainees attend a monthly journal club, monthly Center for Child and Community Health Research (CCHR) research rounds, and monthly meetings to discuss work-in-progress with fellow trainees and the Co-Directors. Trainees are expected to produce scholarly products through their training, including peer-reviewed manuscripts and abstracts to national or international scientific conferences.
Human Behavioral Pharmacology of Substance Abuse
Areas of research training include:
- Clinical pharmacology of drugs of abuse
- Medications development research
- The cognitive neuroscience and behavioral toxicity of drugs of abuse
- Abuse liability assessment
- Behavioral treatment of substance abuse
- Pharmacological treatment of substance abuse
- Integration of behavioral and pharmacological treatments
- Psychiatric comorbidity
- Behavioral and neuropsychiatric assessment
- Cognitive and psychomotor function
- HIV risk behavior assessment
- Clinical trials research methods and management
- Addiction and pregnancy
- Women's health issues
A broad range of abused substances is studied - opioids, cocaine, sedatives, alcohol, hallucinogens, club drugs, tobacco, caffeine. For more information about program resources, faculty, and publications see the Behavioral Pharmacology Research Unit website.
For further information or to apply, contact:
George E. Bigelow, Ph.D.
Professor of Psychiatry and Behavioral Sciences
Director, Behavioral Pharmacology Research Unit (BPRU)
The Johns Hopkins University, School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224-6823